Table of Content

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Increasing Road Accidents And Surgical Procedures
3.2.2. Escalating Palliative Care For Patients Suffering Intensely
3.2.3. Usage Of Abuse Deterrent Formulations To Restrict The Opioid Abuse
3.2.4. Growing Occurrence Of Chronic Pain
3.3. Key Restraints
3.3.1. Misuse Of Opioids
3.3.2. Stringent Regulatory Framework
3.3.3. Opioid Crisis Across The Globe
3.3.4. Increasing Number Of Lawsuits Cases Against Opioids Manufacturers
3.3.5. Rising Occurrence Of Deaths Related To Opioid Overdose

4. Key Analytics
4.1. Key Investment Insights
4.2. Porter’S Five Force Analysis
4.2.1. Buyer Power
4.2.2. Supplier Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Opportunity Matrix
4.4. Vendor Landscape
4.5. Regulatory Framework
4.6. Technological Advancement

5. Market By Product
5.1. Buprenorphine
5.2. Fentanyl
5.3. Hydrocodone
5.4. Morphine
5.5. Oxycodone
5.6. Tramadol
5.7. Other Products

6. Market By Application
6.1. Pain Relief
6.1.1. Cancer Pain
6.1.2. Postoperative Pain Management
6.1.3. Low Back Pain
6.1.4. Orthopedic
6.1.5. Fibromyalgia
6.1.6. Neuropathic
6.2. Anesthesia
6.3. Cough Suppression
6.4. Diarrhea Suppression
6.5. Deaddiction

7. Geographical Analysis
7.1. North America
7.1.1. The United States
7.1.2. Canada

8. Company Profiles
8.1. Acura Pharmaceuticals Inc
8.2. Allergan Plc
8.3. Biodelivery Sciences International Inc
8.4. Cipher Pharmaceuticals Inc
8.5. Collegium Pharmaceutical Inc
8.6. Daiichi Sankyo Inc
8.7. Egalet Corp
8.8. Hikma Pharmaceuticals Plc
8.9. Indivior Inc
8.10. Janssen Pharmaceuticals Inc
8.11. Johnson & Johnson
8.12. Lannett Co. Inc
8.13. Lupin Ltd
8.14. Mylan Nv
8.15. Pfizer Inc
8.16. Purdue Pharma Lp
8.17. Sanofi-Aventis S.A
8.18. Sun Pharmaceutical Industries Limited (Sun Pharma)
8.19. Teva Pharmaceutical Industries Ltd



List of Figures


List of Figures


Figure 1: Key Investment Insights
Figure 2: Porter’S Five Force Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: North America Opioids Drugs Market, Growth Potential, By Product, In 2019
Figure 6: North America Opioids Drugs Market, By Buprenorphine, 2019-2028 (In $ Million)
Figure 7: North America Opioids Drugs Market, By Fentanyl, 2019-2028 (In $ Million)
Figure 8: North America Opioids Drugs Market, By Hydrocodone, 2019-2028 (In $ Million)
Figure 9: North America Opioids Drugs Market, By Morphine, 2019-2028 (In $ Million)
Figure 10: North America Opioids Drugs Market, By Oxycodone, 2019-2028 (In $ Million)
Figure 11: North America Opioids Drugs Market, By Tramadol, 2019-2028 (In $ Million)
Figure 12: North America Opioids Drugs Market, By Other Products, 2019-2028 (In $ Million)
Figure 13: North America Opioids Drugs Market, Growth Potential, By Application, In 2019
Figure 14: North America Opioids Drugs Market, By Pain Relief, 2019-2028 (In $ Million)
Figure 15: North America Pain Relief Market, By Cancer Pain, 2019-2028 (In $ Million)
Figure 16: North America Pain Relief Market, By Postoperative Pain Management, 2019-2028 (In $ Million)
Figure 17: North America Pain Relief Market, By Low Back Pain, 2019-2028 (In $ Million)
Figure 18: North America Pain Relief Market, By Orthopedic, 2019-2028 (In $ Million)
Figure 19: North America Pain Relief Market, By Fibromyalgia, 2019-2028 (In $ Million)
Figure 20: North America Pain Relief Market, By Neuropathic, 2019-2028 (In $ Million)
Figure 21: North America Opioids Drugs Market, By Anesthesia, 2019-2028 (In $ Million)
Figure 22: North America Opioids Drugs Market, By Cough Suppression, 2019-2028 (In $ Million)
Figure 23: North America Opioids Drugs Market, By Diarrhea Suppression, 2019-2028 (In $ Million)
Figure 24: North America Opioids Drugs Market, By Deaddiction, 2019-2028 (In $ Million)
Figure 25: North America Opioids Drugs Market, Country Outlook, 2019 & 2028 (In %)
Figure 26: The United States Opioids Drugs Market, 2020-2028 (In $ Million)
Figure 27: Canada Opioids Drugs Market, 2020-2028 (In $ Million)


List of Tables


TABLE 1: MARKET SNAPSHOT - OPIOIDS DRUGS
TABLE 2: FDA APPROVED OPIOIDS WITH ADF LABELLING
TABLE 3: NUMBER OF LAWSUITS CASES SETTLED BY OPIOIDS MANUFACTURING COMPANIES AND PHARMACIES, 2015–2027
TABLE 4: LIST OF ER/LA OPIOID BRANDED DRUGS, 2017
TABLE 5: LIST OF ER/LA OPIOID GENERIC DRUGS, 2017
TABLE 6: CDC GUIDELINES ON PRESCRIBING OPIOIDS
TABLE 7: PIPELINE ANALYSIS OF OPIOID DRUGS
TABLE 8: NORTH AMERICA OPIOIDS DRUGS MARKET, BY PRODUCT, HISTORICAL YEARS 2016-2019 (IN $ MILLION)
TABLE 9: NORTH AMERICA OPIOIDS DRUGS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA OPIOIDS DRUGS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: NORTH AMERICA OPIOIDS DRUGS MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA PAIN RELIEF MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION):
TABLE 13: NORTH AMERICA PAIN RELIEF MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA OPIOIDS DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 15: NORTH AMERICA OPIOIDS DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)